Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7
Yuan-Yuan Ye1,2,3, Jia-Wei Mei1,2,3, Shan-Shan Xiang1,2,3
1Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Abstract:
Gallbladder carcinoma (GBC), the most common malignant tumour of the bile duct, is highly aggressive and has a poor prognosis. MicroRNA-30a-5p (miR-30a-5p) is an important tumour suppressor that participates in many aspects of carcinogenesis and cancer development. However, the role of miR-30a-5p in GBC development remains to be determined, as do the mechanisms underlying its effects in GBC. Using samples collected from 42 subjects with gallbladder carcinoma (GBC), we showed decreased miR-30a-5p expression in the primary lesions vs. non-tumour adjacent tissues (NATs). Decreased miR-30a-5p was associated with shorter disease-free survival (DFS) and overall survival (OS). Inhibiting miR-30a-5p expression in 2 representative GBC cell lines (GBC-SD and NOZ) increased cell proliferation, migration, invasiveness, as well as β-catenin nuclear translocation, vice versa. In nude mice, NOZ cells transfected with miR-30a-5p mimics grew slower (vs. miR-NC) upon subcutaneous inoculation, and had lower rate of hepatic metastasis upon spleen inoculation. Dual luciferase assay confirmed that E2F transcription factor 7 (E2F7) was a direct target of miR-30a-5p and antagonized the effects induced by miR-30a-5p downregulation in GBC cells. MiR-30a-5p attenuates the EMT and metastasis in GBC cells by targeting E2F7, suggesting miR-30a-5p is a tumour suppressor that may serve as a novel potential prognostic biomarker or molecular therapeutic target for GBC.
Insights
MicroRNA-30a-5p (miR-30a-5p) acts as a tumor suppressor in gallbladder carcinoma (GBC). Lower miR-30a-5p levels correlate with poorer survival and increased metastasis, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gallbladder carcinoma (GBC) is an aggressive bile duct cancer with poor prognosis.
- MicroRNA-30a-5p (miR-30a-5p) is a known tumor suppressor in various cancers.
- The specific role and mechanism of miR-30a-5p in GBC remain unclear.
Purpose of the Study:
- To investigate the role of miR-30a-5p in the development and progression of GBC.
- To elucidate the underlying molecular mechanisms of miR-30a-5p action in GBC.
- To evaluate miR-30a-5p as a potential prognostic biomarker and therapeutic target for GBC.
Main Methods:
- Analysis of miR-30a-5p expression in GBC tissues and adjacent non-tumour tissues (NATs) from 42 patients.
- In vitro studies involving GBC cell lines (GBC-SD, NOZ) to assess the effects of miR-30a-5p inhibition/mimicry on cell proliferation, migration, and invasion.
- In vivo experiments using nude mice to evaluate tumor growth and metastasis.
- Dual luciferase reporter assays to identify direct targets of miR-30a-5p.
Main Results:
- Decreased miR-30a-5p expression was observed in GBC primary lesions compared to NATs.
- Lower miR-30a-5p levels were significantly associated with shorter disease-free survival (DFS) and overall survival (OS).
- miR-30a-5p inhibition promoted GBC cell proliferation, migration, invasion, and β-catenin nuclear translocation, while miR-30a-5p mimics had opposite effects.
- In vivo, miR-30a-5p overexpression reduced tumor growth and hepatic metastasis.
- E2F transcription factor 7 (E2F7) was identified as a direct target of miR-30a-5p, and it antagonized miR-30a-5p's suppressive effects.
Conclusions:
- MiR-30a-5p functions as a tumor suppressor in GBC by attenuating epithelial-mesenchymal transition (EMT) and metastasis.
- The mechanism involves targeting E2F7, thereby inhibiting GBC cell proliferation and metastasis.
- MiR-30a-5p holds promise as a novel prognostic biomarker and a potential molecular therapeutic target for GBC.
Related Concept Videos
MicroRNAs
Cancer Cell Migration through Invadopodia
Gallbladder
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Migration
Cell Migration

